Tranexamic acid for reducing blood transfusions in arthroplasty interventions: A cost-effective practice

European Journal of Orthopaedic Surgery and Traumatology

Volumn 24, Issue 4, 2014, Pages 545-551

  Vigna Taglianti, Federica ^a   Basso, Leonardo ^b   Rolfo, Paola ^b   Brambilla, Romeo ^a   Vaccari, Federica ^b   Lanci, Gisella ^b   Russo, Roberto ^b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b Faculty of Medicine and Surgery School of Nursing   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Arthroplasty intervention; Blood transfusion; Cost benefit evaluation; Hip; Knee; Tranexamic acid

Indexed keywords

HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

AGE; AGED; ARTHROPLASTY; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SEX DIFFERENCE; THROMBOSIS; VERY ELDERLY; BLOOD LOSS, SURGICAL; ECONOMICS; HOSPITAL COST; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; FEMALE; HOSPITAL COSTS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84899915155     PISSN: 16338065     EISSN: 14321068     Source Type: Journal    
DOI: 10.1007/s00590-013-1225-y     Document Type: Article

References (38)

1. Hoylaerts M, Lijnen HR, Collen D (1981) Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 673(1):75-85 (Pubitemid 11149433)
2. Astedt B (1987) Clinical pharmacology of tranexamic acid. Scand J Gastroenterol 137(Suppl):S22-S25
3. Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78:434-440 (Pubitemid 26158834)
4. Benoni G, Fredin H, Knebel R, Nilsson P (2001) Blood conservation with tranexamic acid in total hip Arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 72:442-448 (Pubitemid 33043582)
5. Ekbäck G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckström J, Carlsson O, Schött U (2000) Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 91:1124-1130
6. Good L, Peterson E, Lisander B (2003) Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 90:596-599 (Pubitemid 36592332)
7. Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemelä HM, Mäntylä SK, Kuisma RP, Ylinen JE (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84:839-844 (Pubitemid 27147712)
8. Husted H, Blønd L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P (2003) Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty. Acta Orthop Scand 74:665-669
9. Johansson T, Pettersson L, Lisander B (2005) Tranexamic acid in total hip arthroplasty saves blood and money. Acta Orthopaedica 76:314-319
10. Lemay E, Guay J, Côté C, Roy A (2004) Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anesth 51:31-37 (Pubitemid 38351236)
11. Niskanen RO, Korkala OL (2005) Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthopaedica 76:829-832
12. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92:2503-2513
13. Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83:596-601 (Pubitemid 29458825)
14. Rajesparan K, Biant LC, Ahmad M, Field RE (2009) The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 91:776-783
15. Charoencholvanich K, Siriwattanasakul P (2011) Tranexamic acid reduces blood loss and blood transfusion after tka: a prospective randomized controlled trial. Clin Orthop Relat Res 469:2874-2880
16. Cid J, Lozano M (2005) Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 45:1302-1307 (Pubitemid 41647794)
17. Ho KM, Ismail H (2003) Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 31:529-537 (Pubitemid 37265248)
18. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S (2006) Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 105:1034-1046 (Pubitemid 44655516)
19. Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646-656 (Pubitemid 37254686)
20. Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89:780-785 (Pubitemid 46564282)
21. Dixon T, Shaw M, Ebrahim S, Dieppe P (2004) Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis 63:825-830 (Pubitemid 38850454)
22. American Society of Anesthesiologists (1963) New classification of physical status. Anesthesiology 24:111
23. Wolters U, Wolf T, Stützer H, Schröder T (1996) ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 77:217-222 (Pubitemid 26254509)
24. Burgos E, Gómez-Arnau JI, Díez R, Muñoz L, Fernández- Guisasola J, Garcia del Valle S (2008) Predictive value of six risk scores for outcome after surgical repair of hip fracture in elderly patients. Acta Anaesthesiol Scand 52:125-131
25. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report. Anesthesiology 105:198-208
26. Lozano M, Basora M, Peidro L, Merino I, Segur JM, Pereira A, Salazar F, Cid J, Lozano L, Mazzara R, Macule F (2008) Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 95:39-44 (Pubitemid 351799410)
27. Ralley FE, Berta D, Binns V, Howard J, Naudie DD (2010) One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 468:1905-1911
28. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84:216-220
29. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81:2-10 (Pubitemid 29068441)
30. Keating EM, Meding JB, Faris PM, Ritter MA (1998) Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 12:50-59 (Pubitemid 29022432)
31. Blajchman MA, Vamvakas EC (2006) The continuing risk of transfusion transmitted infections. N Engl J Med 355:1303-1305 (Pubitemid 44465458)
32. Mercuriali F, Inghilleri G (1999) Transfusion risks and limitations. Minerva Anestesiol 65:286-292
33. Thomas D, Wareham K, Cohen D, Hutchings H (2001) Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 86:669-673 (Pubitemid 32409409)
34. Istituto Superiore di Sanità. Registro nazione degli interventi di protesi d'anca. http://www.iss.it/rnpa/index.php. Accessed 24 May 2011
35. Torre M, Manno V, Masciocchi M, Romanini E, Zagra L (2009) Registro nazionale degli interventi di protesi d'anca: basi operative per l'implementazione. Rapporto ISTISAN 09/22
36. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 83:702-705 (Pubitemid 32700674)
37. Ido K, Neo M, Asada Y, Kondo K, Morita T, Sakamoto T, Hayashi R, Kuriyama S (2000) Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 120:518-520
38. Verlicchi F, Desalvo F, Zanotti G, Morotti L, Tomasini I (2011) Red cell transfusion in orthopaedic surgery: a benchmark study performed combining data from different data sources. Blood Transfus 9:383-387